Abstract Purpose of Review The dramatic increase in nonalcoholic fatty liver disease
(NAFLD) and nonalcoholic steatohepatitis (NASH) fostered the development and evaluation …

Nonalcoholic fatty liver disease (NAFLD) is entering a new era in terms of diagnosis and
conceptualization. The term NAFLD is considered to not reflect current knowledge …

Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are
becoming some of the major health problems in well-developed countries, together with the …

Ultrasound and magnetic resonance (MR)-based elastography have demonstrated excellent
performance for noninvasive staging of fibrosis in patients with nonalcoholic fatty liver …

Non-alcoholic fatty liver disease (NAFLD) is the most common diffuse liver disease, with a
worldwide prevalence of 20% to 46%. NAFLD can be subdivided into simple steatosis and …

Non-alcoholic fatty liver disease (NAFLD) represents one of the most common causes of
chronic liver disease, and its prevalence is rising worldwide. The occurrence of non …

Hepatic steatosis is a key histological feature of nonalcoholic fatty liver disease (NAFLD).
The non-invasive quantification of liver fat is now possible due to advances in imaging …

Nonalcoholic fatty liver disease (NAFLD) is an accumulation of extra fat in the liver cells not
caused by alcohol consumption. This disease is an increasingly common condition and the …

Nonalcoholic fatty liver disease (NAFLD) is a common liver disease, with a worldwide
prevalence of 25%. NAFLD is a spectrum that includes nonalcoholic fatty liver defined …

Noninvasive diagnoses of nonalcoholic fatty-liver disease (NAFLD) involve the use of
serologic markers and imaging methods, such as conventional ultrasonography (US) …